![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/7076 | |
A61K 39/00 | |||
A61K 39/395 | |||
C07K 14/725 | |||
C07K 16/28 | |||
C07K 14/705 | |||
A61P 35/00 | |||
A61P 35/02 | |||
A61P 43/00 |
(11) | Number of the document | 3209690 |
(13) | Kind of document | T |
(96) | European patent application number | 15793955.4 |
Date of filing the European patent application | 2015-10-20 | |
(97) | Date of publication of the European application | 2017-08-30 |
(45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/056532 |
Date | 2015-10-20 |
(87) | Number | WO 2016/064929 |
Date | 2016-04-28 |
(30) | Number | Date | Country code |
201462066279 P | 2014-10-20 | US | |
201562162647 P | 2015-05-15 | US | |
201562168710 P | 2015-05-29 | US | |
201562215732 P | 2015-09-08 | US |
(72) |
GILBERT, Mark J., US
|
(73) |
Juno Therapeutics, Inc.,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109,
US
|
(54) | METHODS AND COMPOSITIONS FOR DOSING IN ADOPTIVE CELL THERAPY |
METHODS AND COMPOSITIONS FOR DOSING IN ADOPTIVE CELL THERAPY |